Skip to main content
Premium Trial:

Request an Annual Quote

Genometrix to Provide SNP-Detection Services to Agouron

NEW YORK, March 28 – Genometrix of The Woodlands, Texas, said Wednesday it had reached an agreement to provide SNP-discovery services for Agouron Pharmaceuticals, a subsidiary of Pfizer.

Genometrix did not disclose the terms of the deal, which resulted following a SNP-discovery pilot project.

Spokespeople for Genometrix and Agouron were not immediately available for comment.

Genometrix studies samples provided by its customers, analyzing them using its VistaMorph genotyping technology and its VistaLogic analysis and visualization tools.

SNPs are then screened against the company’s Population Diversity Panel to determine the distribution of the alleles in a diverse population.

Recently, Genometrix also signed animal genomics company AniGenics, as a customer. The company’s other customers include Schering-Plough, Proctor and Gamble, and VistaGen. 

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.